Charles River Laboratories International, Inc. (NYSE:CRL) Stock Upgrade and Financial Overview
Charles River(US:CRL) Financial Modeling Prepยท2025-09-09 16:02Jefferies upgraded NYSE:CRL from Hold to Buy, indicating confidence in the company's growth prospects, especially in its Discovery and Safety Assessment (DSA) segment.Despite facing industry-wide challenges such as foreign exchange pressures and cautious spending in the biotech sector, Charles River Laboratories has slightly outperformed the industry average decline.The company's stock volatility and market interest are evident, with a current market capitalization of approximately $7.97 billion and a tradi ...